texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

Justin W. Wray, M.D., Ph.D.

Justin W. Wray, M.D., Ph.D. Photo

Provider Type: Physician

Specialties:
Board Certifications:
  • Radiation Oncology

Downloads

General Summary

Dr. Wray has specific interests in all aspects of cancer care including both definitive and palliative management of his patients and takes pride in ensuring that all of his patients' needs are met.

Education

  • Fellowship
    University of New Mexico, Albuquerque, NM
  • Residency in Radiation Oncology
    University of Florida, Gainesville, FL
    University of Florida Health Proton Therapy Institute, Jacksonville, FL
  • Internship in Internal Medicine
    University of Florida, Gainesville, FL
  • Medical Doctorate
    University Of New Mexico School Of Medicine, Albuquerque, NM
  • Ph.D. with focus in Cancer Biology
    University Of New Mexico School Of Medicine, Albuquerque, NM

Accolades & Memberships

  • American Association for Cancer Research
  • American College of Radiation Oncology
  • American Medical Association
  • American Society for Radiation Oncology
  • ASTRO
  • Florida Society of Clinical Oncology
  • International Society for Radiation Research Travel Award (2007)
  • Kaplan Teacher of the Year Award, Kaplan, Inc., Albuquerque, NM (December 2008)
  • Lurie and Lurie-Whitlock Scholarship (2009)
  • Particle Therapy Cooperative Group
  • Patient care is “Key” Award, Shands Hospital (2013)
  • Radiation Research Society Travel Award (2006, 2007)
  • Radiological Society of North America
  • Texas Radiology Association

Community Service

  • Ascension Providence Hospital Cancer Committee Chair (January 2021 - Present)
  • QAARC Committee Member-U.S. Oncology (January 2021 - Present)
  • Pathways Committee Member-U.S. Oncology (January 2018 - Present)
  • Panel Member: Late & Long-Term Effects of Treatment Panel; Texas Oncology Survive and Thrive Symposium – Waco (2019)
  • Panel Member: Methodist Digestive Institute discussion on pancreatic cancer (2018)
  • Panel Member: Late & Long-Term Effects of Treatment Panel; Texas Oncology Survive and Thrive Symposium - Arlington (2018)
  • Panel Member: Methodist Digestive Institute discussion on pancreatic cancer (2017)
  • Invited Speaker: 50 Hoops yearly breakfast for prostate cancer awareness. (2018)
  • Chief Resident; Department of Radiation Oncology, University of Florida and the UF Health Proton Therapy Institute (July 2016 – June 2017)
  • King of Knights Social Club, Abilene Christian University (2001 – 2002)

Why a patient should choose treatment at your practice?

At Texas Oncology in Waco, we strive to provide advanced cancer care in a comfortable cancer center close to home. Our staff is always ready to help and works hard to make sure things go smoothly in difficult circumstances. Our doctors are friendly, available and, of course, excellent clinicians.

Why did you become a doctor?

I became enthralled with cancer biology in college and made it my mission to cure this awful disease.

What is your personal philosophy around patient care?

I view patient care as a relationship between a trusted advisor and patient. My goal is to present the possible options and help my patients make the most appropriate decision for themselves and their family. Cancer is a complicated and difficult disease that takes a whole team to defeat.

Publications

  • Stereotactic Body Radiation Therapy for the Treatment of Oligoprogression on Androgen Receptor Targeted Therapy in Castration-Resistant Prostate Cancer

    Oxford Medical Case Reports, 2018

  • Lingual Tonsillectomy Likely Does Not Improve Outcomes for Squamous Cell Carcinoma of the Head and Neck From an Unknown Primary SIte

    American Journal of Clinical Oncology, 2018

  • Stereotactic Body Radiation Therapy for Oligoprogression of Metastatic Disease From Gastrointestinal Cancers: A Novel Approach To Extend Chemotherapy Efficacy

    Oncology Letters, 2017

  • Proton Therapy for Pediatric Hodgkin Lymphoma

    Pediatric Blood & Cancer, 2016

  • Radiation Therapy for Nasal Vestibule Squamous Cell Carcinoma: A 40-Year Experience

    European Archives of Oto-Rhino-Laryngology, 2015

Show all Publications
  • Efficacy of Elective Nodal Irradiation in Skin Squamous Cell Carcinoma of the Face, Ears, and Scalp

    Radiation Oncology, 2015

  • Mechanisms of Oncogenic Chromosomal Translocations

    Annals of the New York Academy of Sciences, 2014

  • The DNA Repair Component Metnase Regulates Chk1 Stability

    Cell Division, 2014

  • PARP1 Is Required for Chromosomal Translocations

    Blood, 2013

  • Methylation of Histone H3 Lysine 36 Enhances DNA Repair by Nonhomologous End-Joining

    Proceedings of the National Academy of Sciences of the USA, 2011

  • The Transposase Domain Protein Metnase/SETMAR Suppresses Chromosomal Translocations

    Cancer Genetics and Cytogenetics, 2010

  • Metnase Promotes Restart and Repair of Stalled and Collapsed Replication Forks

    Nucleic Acids Research, 2010

  • Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells

    PLOS ONE, 2009

  • Metnase Enhances Chromosome Decatenation in Acute Leukemia Cells

    Blood, 2009

  • Down-Regulation of BCCIP Causes Cytoplasm Distribution of p21 Protein

    Cell Cycle, 2009

  • Emi1 Maintains Genomic Integrity During Zebrafish Embryogenesis and Cooperates With p53 in Tumor Suppression

    Molecular and Cellular Biology, 2009

  • Distinct RAD51 Associations With RAD52 and BCCIP in Response to DNA Damage and Replication Stress

    Cancer Research, 2008

  • Mechanisms of Leukemia Translocations

    Current Opinion in Hematology, 2008

  • The Human Set and Transposase Domain Protein Metnase Interacts With DNA Ligase IV and Enhances the Efficiency and Accuracy of Non-Homologous End-Joining

    DNA Repair, 2008

  • The Human Set and Transposase Domain Protein Metnase Interacts With DNA Ligase IV and Enhances the Efficiency and Accuracy of Non-Homologous End Joining

    Nucleic Acids Research, 2008

  • The BRCA2-Interacting Protein BCCIP Functions in RAD51 and BRCA2 Focus Formation and Homologous Recombinational Repair

    Molecular and Cellular Biology, 2005

Research Interest

Dr. Wray has specific interests in all aspects of cancer care including both definitive and palliative management of his patients and takes pride in ensuring that all of his patients' needs are met.

Medical Practice

  • Radiation Oncology, Texas Oncology, Dallas Methodist Hospital, Dallas, TX (August 2017 – June 2019)

Other Information

Dr. Wray enjoys cooking with his wife, spending time at the farm with his two daughters, time on the river with a fly rod, scuba diving, and most any other outdoor adventure.